TrialEuropean journal of pharmacology2022

Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.

Sanaz Abbaspour-Aghdam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.